安罗替尼加培罗单抗作为小细胞肺癌二线治疗的有效性和安全性:多中心、开放标签、单臂II期试验

Changgong Zhang, Jianhua Chen, Huijuan Wu, Jun Wang, Liying Gao, Jun Zhao, Yan Sun, Zhongyao Jia, X. Mu, Chunmei Bai, Rui Wang, Kailiang Wu, Qiang Liu, Yuankai Shi
{"title":"安罗替尼加培罗单抗作为小细胞肺癌二线治疗的有效性和安全性:多中心、开放标签、单臂II期试验","authors":"Changgong Zhang, Jianhua Chen, Huijuan Wu, Jun Wang, Liying Gao, Jun Zhao, Yan Sun, Zhongyao Jia, X. Mu, Chunmei Bai, Rui Wang, Kailiang Wu, Qiang Liu, Yuankai Shi","doi":"10.1016/j.cpt.2024.02.001","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505523,"journal":{"name":"Cancer Pathogenesis and Therapy","volume":"36 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial\",\"authors\":\"Changgong Zhang, Jianhua Chen, Huijuan Wu, Jun Wang, Liying Gao, Jun Zhao, Yan Sun, Zhongyao Jia, X. Mu, Chunmei Bai, Rui Wang, Kailiang Wu, Qiang Liu, Yuankai Shi\",\"doi\":\"10.1016/j.cpt.2024.02.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505523,\"journal\":{\"name\":\"Cancer Pathogenesis and Therapy\",\"volume\":\"36 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Pathogenesis and Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.cpt.2024.02.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Pathogenesis and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.cpt.2024.02.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Predictive models and therapeutic strategies for breast cancer Dynamics of epithelial-mesenchymal plasticity driving cancer drug resistance Spices and culinary herbs for the prevention and treatment of breast cancer: A comprehensive review with mechanistic insights Handy “tools” for studying brain tumors Epithelial-mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1